References
1.
Gillette PC: The mechanism of supraventricular tachycardia in children. Circulation 1976;54:133–139.
2.
Ko JK, Deal BJ, Strasburger JF, et al: Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol 1992;69:1028–1032.
3.
Kugler JD, Danford DA, Deal BJ, et al: Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. N Engl J Med 1994;330:1481–1487.
4.
Yeh SJ, Wang CC, Wen MS, et al: Radiofrequency ablation therapy in atypical or multiple atrioventricular node reentry tachycardias. Am Heart J 1994;128:742–758.
5.
Chen SA, Wu TJ, Chiang CE, et al: Recurrent tachycardia after selective ablation of slow pathway in patients with atrioventricular reentrant tachycardia. Am J Cardiol 1995;76:131–137.
6.
Tai CT, Chen SA, Chiang CE, et al: Electrophysiologic characteristics and radiofrequency catheter ablation in patients with multiple atrioventricular nodal reentry tachycardia. Am J Cardiol 1996;77:52–58.
7.
Yu WC, Chen SA, Tai CT, et al: Electrophysiologic characteristic and radiofrequency catheter ablation of fast-slow form atrioventricular reentrant tachycardia. Am J Cardiol 1997;79:683–686.
8.
Collins KK, Dubin AM, Chiesa NA, Avasarala K, Van Hare GF: Cryoablation versus radiofrequency ablation for treatment of pediatric atrioventricular nodal reentrant tachycardia: initial experience with 4-mm cryocatheter. Heart Rhythm 2006;3:564–570.
9.
Silka MJ, Kron J, Park JK, Halperin BD, McAnulty JH: Atypical forms of supraventricular tachycardia due to atrioventricular node reentry in children after radiofrequency modification of slow pathway conduction. J Am Coll Cardiol 1994;23:1363–1369.
10.
Otomo K, Wang Z, Lazzara R, Jackman WM: Atrioventricular nodal reentrant tachycardia: electrophysiological characteristics of four forms and implications for the reentrant circuit; in Zipes DP, Jalife J (eds): Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, WB Saunders, 2000, pp 514–517.
11.
Tai CT, Chen SA, Chiang CE, et al: Accessory atrioventricular pathways and atrioventricular nodal reentrant tachycardia in teenagers. Jpn Heart J 1995;36:305–317.
12.
Lee PC, Chen SA, Chiang CE, et al: Clinical and electrophysiological characteristics in children with atrioventricular nodal reentrant tachycardia. Pediatr Cardiol 2003;24:6–9.
13.
Otomo K, Wang Z, Lazzara R, Jackman WM: Atrioventricular nodal reentrant tachycardia: electrophysiological characteristics of four forms and implications for the reentrant circuit; in Zipes DP, Jalife J (eds): Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, WB Saunders, 2000, pp 510–514.
14.
Drago F, Grutter G, Silvetti MS, Santis AD, Ciommo VD: Atrioventricular nodal reentrant tachycardia in children. Pediatr Cardiol 2006;27:454–459.
15.
Nawata H, Yamamoto N, Hirao K, et al: Heterogeneity of anterograde fast-pathway and retrograde slow-pathway conduction patterns in patients with the fast-slow form of atrioventricular nodal reentrant tachycardia: electrophysiologic and electrocardiographic considerations. J Am Coll Cardiol 1998;32:1731–1740.
16.
Yamabe H, Shimasaki Y, Honda O, et al: Demonstration of the exact anatomic tachycardia circuit in the fast-slow form of atrioventricular nodal reentrant tachycardia. Circulation 2001;104:1268–1273.
17.
Lee PC, Tai CT, Hwang BT, et al: The electrophysiologic characteristics in patients with only ventricular-pacing inducible slow-fast form atrioventricular nodal reentrant tachycardia. J Interv Cardiac Electrophysiol 2005;14:153–157.
18.
Blurton DJ, Dubin AM, Chiesa NA, Van Hare GF, Collins KK: Characterizing dual atrioventricular nodal physiology in pediatric patients with atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol 2006;17:638–644.
19.
Kannankeril PJ, Fish FA: Sustained slow pathway conduction: superior to dual atrioventricular node physiology in young patients with atrioventricular nodal reentry tachycardia? Pacing Clin Electrophysiol 2006;26:159–163.
20.
Hwang C, Martin DJ, Goodman JS, et al: Atypical atrioventricular nodal reciprocating tachycardia masquerading as tachycardia using a left-sided accessory pathway. J Am Coll Cardiol 1997;30:215–218.
21.
Yano K, Horikawa T, Hirao K, et al: Slow-fast form of atrioventricular nodal reentrant tachycardia with eccentric retrograde left-sided activation. Jpn Heart J 1999;40:655–664.
22.
Sakabe K, Wakatzuki T, Fujinaga H, et al: Patient with atrioventricular node reentrant tachycardia with retrograde left-sided activation. Jpn Heart J 2000;41:227–234.
23.
Chen J, Anselme F, Smith T, et al: Standard right atrial ablation is effective for atrioventricular nodal reentry with earliest activation in the coronary sinus. J Cardiovasc Electrophysiol 2004;15:2–7.
24.
Tondo C, Otorno K, McClelland J, et al: Atrioventricular nodal reentrant tachycardia: is the reentrant circuit confined in the right atrium? J Am Coll Cardiol 1996;27:159A.
25.
Jais P, Haissaguerre M, Shah DC, et al: Successful radiofrequency ablation of a slow atrioventricular nodal pathway on the left posterior atrial septum. Pacing Clin Electrophysiol 1999;22:525–527.
26.
Sorbera C, Cohen M, Woolf P, et al: Atrioventricular nodal reentry tachycardia: slow pathway ablation using the transseptal approach. Pacing Clin Electrophysiol 2000;23:1343–1349.
27.
Dizon J, Reiffel J, Kassotis J, et al: Change in the retrograde atrial activation sequence following radiofrequency modification of the atrioventricular node: implications for the electrophysiologic circuit of a variant of atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol 2003;14:461–466.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the...
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
